Trading Signals: ARCT Stock Price Prediction and Forecast (Wed. May. 22, 2013 - Wed. Sep. 27, 2023)(Arcturus Therapeutics)
| ARCT latest price $27.5700 (-5.09%) ($27.5700 - $27.5700) on Wed. Mar. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.5% (three month average) | RSI | 72 | Latest Price | $27.5700(-5.09%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ARCT advances 18.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ARCT advance at 0% a week (0% probability) IBB(56%) XBI(54%) ARKG(49%) IWO(46%) ARKK(45%) | Factors Impacting ARCT price | ARCT will decline at least -3.25% in a week (0% probabilities). VIXM(-30%) UUP(-18%) VXX(-11%) TBT(-3%) TLT(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.25% (StdDev 6.5%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $27.72(-0.54%) | 10 Day Moving Average | $26.84(2.72%) | 20 Day Moving Average | $23.12(19.25%) | To recent high | -30.1% | To recent low | 56.2% | Market Cap | $560m | | | | Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.July 7, 2020 ARCT develops mRNA based covid vaccine. Now it's still in preclinical stage, and plan to start phase I clinic trail this summer. |